0000000000572984

AUTHOR

M. Wood

showing 4 related works from this author

Searches for lepton number violation and resonances in K± → πμμ decays

2017

The NA48/2 experiment at CERN collected a large sample of charged kaon decays to final states with multiple charged particles in 2003–2004. A new upper limit on the rate of the lepton number violating decay K±→π∓μ±μ± is reported: B(K±→π∓μ±μ±)<8.6×10−11 at 90% CL. Searches for two-body resonances X in K±→πμμ decays (such as heavy neutral leptons N4 and inflatons χ ) are also presented. In the absence of signals, upper limits are set on the products of branching fractions B(K±→μ±N4)B(N4→πμ) and B(K±→π±X)B(X→μ+μ−) for ranges of assumed resonance masses and lifetimes. The limits are in the (10−11,10−9) range for resonance lifetimes below 100 ps.

leptonBEAM01 natural sciences7. Clean energyPhysics Particles & FieldsHigh Energy Physics - ExperimentLIMITSkaon physicsCERNIntermediate statelepton number violation neutrinos dark matter kaon physicsPhysicsVMSMLarge Hadron ColliderPhysicsCharge KaonsneutrinosNuclear and High Energy Physics; CERN; leptonsHigh Energy Physics - Experiment; Charge Kaons; Lepton number violationNuclear & Particles PhysicsCharged particlelcsh:QC1-999NEUTRAL HEAVY-LEPTONSPhysics Nuclearlepton number violationPhysical SciencesParticle physicsNuclear and High Energy Physicsleptonskaon decays lepton number violationNuclear and High Energy Physics lepton kaon meson lepton number violation NA48Socio-culturaleAstronomy & AstrophysicsUPPER-BOUNDSdark matterNuclear physics0202 Atomic Molecular Nuclear Particle And Plasma Physics0103 physical sciencesDARK-MATTERPARTICLES010306 general physicsScience & Technologykaon decays010308 nuclear & particles physicsBranching fractionResonanceInflatonLepton numberkaon mesonNA48High Energy Physics::Experimentlcsh:PhysicsLepton
researchProduct

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

2021

Abstract Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in su…

MaleCOVID-19 Vaccinesafe surgery; vaccination modelling; COVID-19Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]MULTICENTERComorbidity030230 surgery0302 clinical medicinephase 3 clinical trial (topic)Case fatality rateProspective StudiesSARS-CoV-2 Vaccination Safe surgeryCOVID-19/epidemiologySARS-CoV-2 ; vaccination ; safe surgeryeducation.field_of_studycase fatality rateVaccinationVaccinationAdolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Period; Prospective Studies; SARS-CoV-2; Vaccination; Young Adulthealth care policyElective Surgical Procedures030220 oncology & carcinogenesisvaccination modellingPreoperative PeriodCOVID-19; SARS-CoV-2; cancer; vaccination; outcome; mortality; infection; modellingCohort studyprospective studyHumanmedicine.medical_specialtyArticle03 medical and health sciencesSARS-CoV-2 vaccinationSDG 3 - Good Health and Well-beingCOVID-19 Vaccines/pharmacologyHumansVaccination/methodsElective surgeryeducationAgedScience & TechnologyElective Surgical Procedureadult; aged; Article; cancer grading; cancer surgery; case fatality rate; computer assisted tomography; elective surgery; female; follow up; health care policy; human; incidence; infection rate; infection risk; major clinical study; male; middle aged; mortality; outcome assessment; phase 3 clinical trial (topic); preoperative care; prospective study; sensitivity analysis; seroprevalence; Severe acute respiratory syndrome coronavirus 2; vaccination; young adult; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Postoperative Complications; Preoperative Period; SARS-CoV-2; Vaccination; surgery.Cura preoperatòriamajor clinical studymortalityinfectionProspective StudieincidenceSurgeryHuman medicinePostoperative Complication610 Medizin und GesundheitAcademicSubjects/MED00910Settore MED/18 - CHIRURGIA GENERALESettore MED/29 - CHIRURGIA MAXILLOFACCIALEcomputer assisted tomographyESTUDOS PROSPECTIVOSsurgerysafe surgeryPostoperative Complicationssensitivity analysisSevere acute respiratory syndrome coronavirus 2preoperative careVacunacióProspective cohort studyseroprevalenceIncidence (epidemiology)covidElective Surgical Procedures/methodsMiddle Agedcancer gradingCOVID vaccinationoutcome/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSARS-CoV-2; vaccination; surgeryOriginal ArticleFemalecancer surgeryAcademicSubjects/MED00010Life Sciences & BiomedicineAdultCOVID-19 VaccinesAdolescentinternational prospective cohort studyPostoperative Complications/prevention & controlPopulationinfection rateSARS-CoV-2/immunologyNOmodellingYoung Adultmedicinefollow upcancerddc:610infection riskoutcome assessmentLS7_4business.industrySARS-CoV-2Number needed to vaccinatePreoperative careCOVID-193126 Surgery anesthesiology intensive care radiologySettore MED/18Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]elective surgeryEmergency medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe British Journal of Surgery
researchProduct

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

2019

Background: Results from retrospective studies suggest that use of neuromuscular blocking agents during general anaesthesia might be linked to postoperative pulmonary complications. We therefore aimed to assess whether the use of neuromuscular blocking agents is associated with postoperative pulmonary complications. Methods: We did a multicentre, prospective observational cohort study. Patients were recruited from 211 hospitals in 28 European countries. We included patients (aged ≥18 years) who received general anaesthesia for any in-hospital procedure except cardiac surgery. Patient characteristics, surgical and anaesthetic details, and chart review at discharge were prospectively collecte…

Pulmonary and Respiratory Medicinepulmonary complications muscle relaxants Post-anaesthesia complicationsNeuromuscular Blockadepulmonary complication muscle relaxantneuromuscular block ; postoperative pulmonary complicationbusiness.industryRetrospective cohort studypost-operative pulmonary complicationsNeuromuscular monitoringNeuromuscular Blocking AgentsSugammadexNOAnaesthesia03 medical and health sciences0302 clinical medicine030228 respiratory systemAnesthesiaMedicineGeneral anaesthesiaNeuromuscular Agents030212 general & internal medicineMED/41 - ANESTESIOLOGIAProspective cohort studybusinessmedicine.drug
researchProduct

Sensitivity of the Cherenkov Telescope Array to a dark matter signal from the Galactic centre

2021

Full list of authors: Acharyya, A.; Adam, R.; Adams, C.; Agudo, I.; Aguirre-Santaella, A.; Alfaro, R.; Alfaro, J.; Alispach, C.; Aloisio, R.; Alves Batista, R.; Amati, L.; Ambrosi, G.; Angüner, E. O.; Antonelli, L. A.; Aramo, C.; Araudo, A.; Armstrong, T.; Arqueros, F.; Asano, K.; Ascasíbar, Y. Ashley, M.; Balazs, C.; Ballester, O.; Baquero Larriva, A.; Barbosa Martins, V.; Barkov, M.; Barres de Almeida, U.; Barrio, J. A.; Bastieri, D.; Becerra, J.; Beck, G.; Becker Tjus, J.; Benbow, W.; Benito, M.; Berge, D.; Bernardini, E.; Bernlöhr, K.; Berti, A.; Bertucci, B.; Beshley, V.; Biasuzzi, B.; Biland, A.; Bissaldi, E.; Biteau, J.; Blanch, O.; Blazek, J.; Bocchino, F.; Boisson, C.; Bonneau Arbe…

Cherenkov Telescope ArrayMATÉRIA ESCURAscale: TeVAstronomyatmosphere [Cherenkov counter]dark matter experimentDark matter theoryenergy resolutionGamma ray experimentsParticleAstrophysicscosmic background radiation01 natural sciences7. Clean energyHigh Energy Physics - Phenomenology (hep-ph)benchmarkWIMPHESSenergy: fluxTeV [scale]relativistic [charged particle]gamma ray experimentMAGIC (telescope)Monte CarloEvent reconstructionPhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)Contractionspatial distributiontrack data analysisPhysicsdensity [dark matter]ClumpyAstrophysics::Instrumentation and Methods for AstrophysicsimagingHigh Energy Physics - Phenomenologydark matter experiments; dark matter theory; gamma ray experiments; galaxy morphologyDark matter experimentsFísica nuclearVERITASAstrophysics - High Energy Astrophysical PhenomenaSimulationsnoiseWIMPAstrophysics::High Energy Astrophysical PhenomenaDark mattersatelliteCosmic background radiationFOS: Physical sciencesAnnihilationdark matter: densityAstrophysics::Cosmology and Extragalactic AstrophysicsCherenkov counter: atmosphereheavy [dark matter]530annihilation [dark matter]GLASTDark matter experiments; Dark matter theory; Galaxy morphology; Gamma ray experimentscosmic radiation [p]0103 physical sciencesCherenkov [radiation]Candidatesddc:530AGNCherenkov radiationRadiative Processesthermal [cross section]010308 nuclear & particles physicsFísicadark matter: annihilationGamma-Ray SignalsCherenkov Telescope Array ; dark matter ; Galactic Center ; TeV gamma-ray astronomyAstronomy and AstrophysicsMassCherenkov Telescope Arrayradiation: CherenkovsensitivityMAGICGalaxyAstronomíadark matter: heavygamma rayp: cosmic radiation[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]correlationcharged particle: relativisticflux [energy]Galaxy morphology/dk/atira/pure/subjectarea/asjc/3100/3103galaxysupersymmetry[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]cross section: thermal
researchProduct